NovoCure Limited (NVCR)

NovoCure Revenue

NovoCure had revenue of $174.06M in the quarter ending March 31, 2026, with 12.30% growth. This brings the company's revenue in the last twelve months to $674.41M, up 8.48% year-over-year. In the year 2025, NovoCure had annual revenue of $655.35M with 8.28% growth.

• Revenue (ttm): $674.41M
• Revenue Growth: +8.48%
• P/S Ratio: 3.11
• Revenue / Employee: $420,196
• Employees: 1,605
• Market Cap: 2.10B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	655.35M	50.13M	8.28%
Dec 31, 2024	605.22M	95.88M	18.82%
Dec 31, 2023	509.34M	-28.50M	-5.30%
Dec 31, 2022	537.84M	2.81M	0.53%
Dec 31, 2021	535.03M	40.66M	8.23%

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 12, 2026

Data Sources Report a data error